TNXP
Tonix Pharmaceuticals Holding Corp
10.60$
-1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 1,733.4% | – | 1,241.7% | 61.0% | 76.9% | 65.3% | |
| – | – | – | – | – | – | -1,733.4% | – | -1,241.7% | 39.0% | 23.1% | 34.7% | |
| – | – | – | – | – | – | 1,240.8% | – | 907.0% | 1,115.5% | 400.7% | 339.4% | |
| – | – | – | – | – | – | 492.6% | – | 334.7% | 447.4% | 33.7% | 669.0% | |
| – | – | – | – | – | – | 1,733.4% | – | 1,241.7% | 1,562.9% | 1,377.4% | 993.7% | |
| – | – | – | – | – | – | -1,733.4% | – | -1,241.7% | -1,523.9% | -1,354.3% | -959.1% | |
| – | – | – | – | – | – | 0.0% | – | 87.6% | – | 12.2% | 0.7% | |
| – | – | – | – | – | – | -1,731.7% | – | -1,221.0% | -1,501.8% | -1,288.3% | -946.2% | |
| – | – | – | – | – | – | -2.6% | – | 53.0% | 0.0% | -11.6% | – | |
| – | – | – | – | – | – | -1,729.2% | – | -1,274.0% | -1,501.8% | -1,288.3% | -946.2% | |
| – | – | – | – | – | – | -1,732.5% | – | -1,227.8% | -1,446.5% | -736.3% | -930.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.